Privacy Policy

Effective September 18, 2018

Osmotica Pharmaceuticals plc and its subsidiaries, including without limitation, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC (collectively, "we" or "Osmotica") appreciate the sensitivity and privacy with which your health inquiries should be handled. This Policy describes how we collect, protect and use information received and collected from you by means of our websites at osmotica.com , verticalpharma.com, trigenlab.com and any other website that links to this Policy (collectively, the "Website"). It does not apply to information that we gather or collect using any other method. We urge you to read our Policy so that you will understand both our commitment to you and your privacy, and how you can participate in that commitment. By accessing or using this Website, you agree to this Privacy Policy.

What Information Do We Collect From You?

Our Website enables you to review information regarding our company and our products. We collect several types of information from and about users of our Website, including information:

  • by which you may be personally identified, such as name, e-mail address, telephone number, or any other identifier that you might provide to us by which you may be contacted online or offline ("Personal Information");
  • that is about you but individually does not identify you; and/or
  • about your internet connection, the equipment you use to access our Website, and usage details.

We collect this information:

  • directly from you when you provide it to us, such as if you contact us.
  • automatically as you navigate through the Website. Information collected automatically may include usage details, IP addresses, and information collected through cookies, Web Beacons (as defined below), and other tracking technologies (see "Do We Use Cookies?", below).

Do We Use "Cookies"?

Yes. A cookie is a bit of electronic data that is stored on a user's hard drive containing information about the user. Cookies can save time, as they can store information about a user so that same information does not have to be entered on subsequent visits to the same website. While your browser may accept cookies automatically, you can change the settings on your browser to prevent our cookies from being automatically downloaded, or to notify you that they are ready to be downloaded. The latter will give you the option of whether or not you want to accept our cookies. If you decide to decline our cookies, however, some of our Website's features or services may not function as well as they would have had you accepted our cookies. Our Website may contain very small, transparent, electronic images called "Web Beacons" that allow us to count users who have visited the Website pages on which they are located. Web Beacons are not used to access your Personal Information, but rather are a method for us to assemble aggregated statistics about the usage of our Website. While you cannot decline Web Beacons, you can decline all cookies and therefore render the Web Beacons ineffective. We use information collected through cookies or Web Beacons to better understand, customize and improve user experience with our Website, services and offerings as well as to manage our advertising. For example, we may use web analytics services that leverage such information to help us to understand how visitors engage with and navigate our Website, e.g., how and when pages in a site are visited and by how many visitors. We are also able to offer our visitors a more customized, relevant experience on our Website by using this information to deliver content and functionality based on your preferences and interests. If we have collected your Personal Information, e.g., through a registration or a request for certain materials, we may associate this Personal Information with information gathered through cookies or Web Beacons. This allows us to offer increased personalization and functionality on the Website.

How We Use Information We Collect From You:

We use the contact information that you provide to us in order to communicate with you. You may unsubscribe from Osmotica emails at any time by clicking on the "unsubscribe" link in the footer of the email. Removing your name from the email list may take up to 10 days. We do not disclose your Personal Information to third parties except as follows:

  • We disclose your Personal Information to companies and individuals who perform duties on our behalf, such as website hosting, marketing and customer service companies. While these companies may have access to your Personal Information in order to perform their jobs, they are prohibited from sharing your information with any other individual or company.
  • We will consider releasing, and may release, Personal Information to third parties to comply with valid legal requirements such as a law, regulation, search warrant, subpoena or court order.
  • We also may release Personal Information in order to prevent a crime, for national security, to protect our rights and property and to protect the personal safety of our users or the public.
  • We disclose your Personal Information to third parties if you consent for us to do so. For example, if you indicate that you want to receive offers and promotions from our partner companies, we will send your information to them according to your interests and preferences. If you decide to share your contact information in this manner, you will be provided with instructions regarding how to opt out of receiving such information in the future if you decide you no longer wish to do so.
  • We may disclose and transfer your Personal Information to a third party that acquires all or a substantial portion of our business, whether by way of merger, consolidation or purchase of all or a substantial portion of our assets. You will be notified if all or a substantial portion of our business is sold by email or a notice posted on the Website.
  • In addition, in the unlikely event that we become the subject of a voluntary or involuntary bankruptcy proceeding, we or our trustee in bankruptcy may sell, license or otherwise dispose of your Personal Information in a transaction approved by a bankruptcy court.
  • We may use information that does not allow you to be identified ("Aggregate Information") to better design our Website and to share with our advertisers. For example, we may tell an advertiser that a certain number of individuals visited a certain area on our Website. We also might share Aggregate Information regarding the overall demographics of the users of our Website, such as their age, gender, or occupation. Depending on the circumstances, we may or may not charge advertisers for this information.
  • Finally, we may disclose your Personal Information for any other purpose disclosed by us when you provided the information.

How We Protect The Information You Give To Us:

We have implemented measures designed to secure your Personal Information from accidental loss and from unauthorized access, use, alteration, and disclosure. We keep your Personal Information on a central database on a secured network in the United States with access limited to a small number of persons. By using the Website, you grant Osmotica and all other persons or entities involved in the operation of our Website the right to receive, transmit, monitor, retrieve, store and use your Personal Information, including information that may be privileged and confidential under applicable state and federal laws, in connection with the operation of our Website and our maintenance of your Personal Information. Although we have made reasonable efforts to safeguard the confidentiality of your Personal Information, we cannot promise, and you should not expect, that your Personal Information will always stay private. We cannot guarantee that unauthorized third parties will never be able to circumvent our security measures and obtain access to your Personal Information and use it for improper purposes. As a user of the Website, you agree that you assume all risks regarding your use of the Website, transmissions made over the Internet generally, and your sharing of your Personal Information.

How You Can Access, Correct Or Delete Your Personal Information:

We are committed to providing you reasonable and practical access to your Personal Information to determine if it is accurate. If you would like a hard copy of the Personal Information that we have collected from you, you may contact us at info@osmotica.com. To protect your privacy and security, we will also take reasonable steps to verify your identity before sending your Personal Information or making corrections to it. In order to review and edit your Personal Information, please send us an email at info@osmotica.com and request to do so. You may opt-out of or discontinue receiving communications from us by sending an e-mail to info@osmotica.com. If you no longer wish to use our Website, you have the option of doing so. We may retain historical records that include some of your Personal Information.

Your California Privacy Rights

California Civil Code Section § 1798.83 permits users of our Website that are California residents to request certain information regarding our disclosure of Personal Information to third parties for their direct marketing purposes. To make such a request, please send an email to info@osmotica.com.

Children's Privacy

Our Website is not intended for children under 18 years of age. No one under age 18 may provide any information to the Website. We do not knowingly collect Personal Information from children under 18. If you are under 18, do not use or provide any information on this Website. If we learn we have collected or received Personal Information from a child under 18 without verification of parental consent, we will delete that information. If you believe we might have any information from or about a child under 18, please contact us using the information below.

How To Contact Us:

Should you have other questions or concerns about this Privacy Policy, or any comments, concerns or general feedback, please do not hesitate to contact us by sending us an email at info@osmotica.com or at the following: Osmotica Pharmaceuticals plc, 400 Crossing Boulevard, Bridgewater, NJ 08807 Phone: 908-809-1300 Fax: 908-809-1301

How We Announce Changes To Our Privacy Policy:

If we change our Privacy Policy, we will post the changes thereto on our Website. Your use of the Website constitutes acceptance of our Privacy Policy, and your continued usage after such changes are posted constitutes acceptance of such revised Privacy Policy.

Brian Markison, Chairman of the Board and Chief Executive Officer

Brian Markison has served as Chairman of the Board and Chief Executive Officer of Osmotica since 2016. Mr. Markison is a healthcare industry veteran, with more than 30 years of operational, marketing, commercial development and sales experience with international pharmaceutical companies. He has served as an advisor to Avista Capital Partners since September 2012. He previously served as the President, Chief Executive Officer and board member of Fougera Pharmaceuticals, Inc., a dermatology-focused specialty pharmaceutical company sold to Sandoz Ltd., the generics division of Novartis AG. Before leading Fougera, Mr. Markison was Chairman and Chief Executive Officer of King Pharmaceuticals, Inc., which he joined as Chief Operating Officer in March 2004. He was promoted to President and Chief Executive Officer later that year and elected Chairman in 2007. Prior to joining King Pharmaceuticals, Inc., Mr. Markison held various senior leadership positions at Bristol-Myers Squibb. He serves as Chairman of the Board of Lantheus Holdings, Inc. and is on the board of directors of Avista Healthcare Public Acquisition Corp., National Spine and Pain Centers, LLC and Braeburn Pharmaceuticals, Inc. He is also a Director of the College of New Jersey.

James Schaub, Executive Vice President and Chief Operating Officer

James Schaub has served as our Executive Vice President and Chief Operating Officer since 2016. Mr. Schaub previously served as Chief Operating Officer of Trigen Laboratories and as Vice President of M&A at Fougera Pharmaceuticals, Inc. He also held several commercial roles of increasing responsibility at King Pharmaceuticals, Inc. Mr. Schaub is a graduate of Middlebury College and holds an M.B.A. from Rutgers Business School.

Andrew Einhorn, Chief Financial Officer

Andrew Einhorn joined as Chief Financial Officer in September 2017. Mr. Einhorn has more than 15 years of experience in the pharmaceutical industry. Mr. Einhorn previously served as the Chief Financial Officer of Edge Therapeutics, Inc., a clinical-stage biotechnology company that he joined as Executive Vice President of Corporate Development in 2013. Prior to that, he was a co-founder, Executive Vice President and Chief Financial Officer at Oceana Therapeutics, Inc. Previously, Mr. Einhorn was a co-founder and Chief Financial Officer of both Esprit Pharma, Inc. and ESP Pharma, Inc. Mr. Einhorn is licensed as a Certified Public Accountant in the State of New Jersey and holds a B.S. in Finance and Accounting from American University.

Christopher Klein, General Counsel and Secretary

Christopher Klein has served as our General Counsel and Secretary since December 2013. Mr. Klein previously served as the General Counsel of Fougera Pharmaceuticals, Inc. and as Deputy General Counsel at King Pharmaceuticals, Inc. Mr. Klein spent six years in senior legal roles with Bristol-Myers Squibb Company. Mr. Klein holds a B.A. in Biology from Adelphi University, an M.A. in Education from Columbia University and a J.D. from Fordham University.

Tina deVries, Ph.D., Executive Vice President, Research and Development

Tina deVries, Ph.D. became our Executive Vice President, Research & Development in May 2016. Dr. deVries most recently served as the Principal of TM deVries Consulting, LLC. She was previously Vice President of Nonclinical and Clinical Pharmacology at Actavis plc following its 2013 acquisition of Warner Chilcott plc where she served as the Vice President of Clinical Pharmacology. Dr. deVries holds a B.S. in Pharmacy and a Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from The Ohio State University.

Lynn Palmer, Senior Vice President, Technical Operations

Lynn Palmer has served as our Senior Vice-President, Technical Operations since June 2017. Prior to that, he served as Vice-President, Manufacturing from February of 2016. Before Osmotica, Mr. Palmer served as Executive-Vice-President, Engineering at King Pharmaceuticals for six years. Previously Mr. Palmer led Engineering at Mallinckrodt Inc. (a division of Tyco Healthcare), and served as Vice-President, Production at Inbrand Corporation. Prior to Inbrand, he served in progressive manufacturing management roles at Kimberly-Clark Corporation from 1982-1996. Mr. Palmer holds a Bachelor of Applied Science in Paper Science and Engineering from Miami University.

Jarret Miller, Executive Vice President, Human Resources

Jarret Miller has served as our Executive Vice President, Human Resources since January 2016. Mr. Miller has more than 20 years of Human Resources experience in various roles of increasing responsibility. He previously served as the Head of Human Resources Operations and Services for the Americas at Teva Pharmaceuticals, Inc. Prior to that, he held the positions of Vice President, Human Resources at ConvaTec, Inc. and Senior Vice President, Human Resources at King Pharmaceuticals, Inc. Mr. Miller holds a B.S. in Statistics and Biometry from Cornell University.

David Burgstahler

David Burgstahler has been a director since 2016. Mr. Burgstahler is the President and Co-Managing Partner of Avista Capital Partners and is the Chief Executive Officer of Avista Healthcare Public Acquisition Corp. Mr. Burgstahler was a founding partner of Avista Capital Partners in 2005 and since 2009, has been President of Avista Capital Partners. Prior to forming Avista Capital Partners, Mr. Burgstahler was a partner of DLJ Merchant Banking Partners. Previously, Mr. Burgstahler worked at Andersen Consulting (now known as Accenture plc) and McDonnell Douglas (now known as The Boeing Company). Mr. Burgstahler currently serves as a director of Avista Healthcare Public Acquisition Corp., Inform Diagnostics, Inc., Kramer Laboratories, Inc., United BioSource Corporation and WideOpenWest, Inc. He is also a Trustee of the Trinity School in New York City. Mr. Burgstahler holds a B.S. in Aerospace Engineering from the University of Kansas and an M.B.A. from Harvard Business School.

Sriram Venkataraman

Sriram Venkataraman has been a director since 2016. He is a Partner of Avista Capital Partners, having joined in 2007. Prior to joining Avista Capital Partners, Mr. Venkataraman was a Vice President in the Healthcare Investment Banking group at Credit Suisse Group AG. Previously, he worked at GE Healthcare (formerly known as GE Medical Systems). He currently serves as a director of OptiNose, Inc., Inform Diagnostics, Inc. and National Spine & Pain Centers Holdings, LLC and previously served as a director of AngioDynamics, Inc., Lantheus Holdings, Inc. and Zest Anchors, Inc. Mr. Venkataraman holds an M.S. in Electrical Engineering from the University of Illinois, Urbana-Champaign and an M.B.A. from The Wharton School at the University of Pennsylvania.

Daniel Sielecki

Daniel Sielecki became a director of Osmotica Holdings Corp Ltd. in 2007 and joined the board of directors in 2016 in connection with the combination of Osmotica Holdings Corp Ltd. and Vertical/Trigen. Mr. Sielecki has worked at Laboratorios Phoenix S.A since 1975 and currently serves as a director of Simali S.A., Petroquımica Cuyo S.A and PEPCA S.A. He previously served as a director of Disprofarma S.A.

Carlos Sielecki

Carlos Sielecki became a director of Osmotica Holdings Corp Ltd. in 2007 and joined the board of directors in 2016 in connection with the combination of Osmotica Holdings Corp Ltd. and Vertical/Trigen. Mr. Sielecki currently serves as a director of Simali S.A. and holds a degree in architecture from the University of Buenos Aires.

Juan Vergez

Juan Vergez became a director in 2016. Mr. Vergez served as the President of Osmotica Argentina from November 2010 to May 2016, and as the New Business Director of Osmotica Argentina from May 2016 to December 2017. Mr. Vergez previously served as a director of Nutrifoods, S.A. and has more than 40 years of experience in the pharmaceutical industry.